{"id":"amodiaquine-artesunate-artemether-lumefantrine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amodiaquine's mechanism of action involves the inhibition of the parasite's heme detoxification pathway, which is essential for the parasite's survival. Artesunate and artemether-lumefantrine, on the other hand, rapidly kill the parasite by generating reactive oxygen species that damage the parasite's cell membrane.","oneSentence":"Amodiaquine is a chloroquine derivative that acts as an antimalarial agent by inhibiting the parasite's heme detoxification pathway, while artesunate and artemether-lumefantrine are artemisinin-based combination therapies that rapidly kill the parasite.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:25.177Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of uncomplicated malaria"},{"name":"Treatment of severe malaria"}]},"trialDetails":[{"nctId":"NCT06967519","phase":"PHASE4","title":"OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-12-18","conditions":"Malaria, Hiv","enrollment":380},{"nctId":"NCT07362498","phase":"","title":"Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya","status":"COMPLETED","sponsor":"Strathmore University","startDate":"2020-06-01","conditions":"Malaria Falciparum","enrollment":316},{"nctId":"NCT05951595","phase":"PHASE3","title":"A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-09-11","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":1680},{"nctId":"NCT03923725","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-09-01","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":2583},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":"Malaria","enrollment":870},{"nctId":"NCT05764746","phase":"PHASE2, PHASE3","title":"Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial","status":"RECRUITING","sponsor":"Muhimbili University of Health and Allied Sciences","startDate":"2023-05-01","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":384},{"nctId":"NCT06076213","phase":"PHASE4","title":"Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2023-05-01","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":1260},{"nctId":"NCT05550909","phase":"PHASE2","title":"Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2022-10-17","conditions":"Malaria,Falciparum","enrollment":100},{"nctId":"NCT06300970","phase":"PHASE4","title":"Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2022-08-09","conditions":"Plasmodium Falciparum, Malaria, Uncomplicated Malaria","enrollment":352},{"nctId":"NCT03939104","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-06-30","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":103},{"nctId":"NCT04618523","phase":"PHASE4","title":"Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2020-10-26","conditions":"Malaria","enrollment":1117},{"nctId":"NCT00297882","phase":"PHASE3","title":"Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2006-07","conditions":"Malaria","enrollment":816},{"nctId":"NCT04877626","phase":"PHASE4","title":"Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia)","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2008-09","conditions":"P. Falciparum Malaria","enrollment":210},{"nctId":"NCT02627456","phase":"PHASE1","title":"Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-12-09","conditions":"Malaria","enrollment":409},{"nctId":"NCT04829695","phase":"PHASE4","title":"Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon","status":"UNKNOWN","sponsor":"University of Yaounde 1","startDate":"2021-04-05","conditions":"Falciparum Malaria","enrollment":184},{"nctId":"NCT04565184","phase":"PHASE4","title":"Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2019-05-09","conditions":"Malaria,Falciparum","enrollment":242},{"nctId":"NCT00123552","phase":"PHASE3","title":"Longitudinal Antimalarial Combinations in Uganda","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2004-11","conditions":"Malaria","enrollment":601},{"nctId":"NCT04370977","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2018-03-21","conditions":"Malaria","enrollment":630},{"nctId":"NCT03768908","phase":"PHASE4","title":"Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005","status":"COMPLETED","sponsor":"Professor Anders Björkman","startDate":"2005-01-05","conditions":"Plasmodium Falciparum Malaria","enrollment":359},{"nctId":"NCT03764527","phase":"PHASE4","title":"Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar","status":"COMPLETED","sponsor":"Professor Anders Björkman","startDate":"2002-11-01","conditions":"Plasmodium Falciparum Malaria","enrollment":408},{"nctId":"NCT01845701","phase":"PHASE3","title":"Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2010-03","conditions":"Malaria","enrollment":720},{"nctId":"NCT02453308","phase":"PHASE2, PHASE3","title":"A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-08","conditions":"Malaria, Falciparum","enrollment":1110},{"nctId":"NCT01967472","phase":"NA","title":"Adherence to Antimalarial Drugs in Sierra Leone","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-09-16","conditions":"Malaria","enrollment":1145},{"nctId":"NCT02940756","phase":"PHASE4","title":"Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2017-03-15","conditions":"Malaria","enrollment":1615},{"nctId":"NCT00119145","phase":"PHASE4","title":"Kintampo Trial of Combination Therapy for Malaria","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2005-06","conditions":"Malaria","enrollment":510},{"nctId":"NCT02242799","phase":"PHASE1","title":"Dolutegravir Interactions With Artemisinin-based Combination Therapies","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2015-06","conditions":"Malaria, HIV","enrollment":46},{"nctId":"NCT02741024","phase":"PHASE4","title":"Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo","status":"COMPLETED","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2013-10","conditions":"Malaria","enrollment":288},{"nctId":"NCT00852423","phase":"PHASE3","title":"Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2010-06","conditions":"Malaria in Pregnancy","enrollment":3428},{"nctId":"NCT02637128","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2014-03","conditions":"MALARIA, FALCIPARUM","enrollment":452},{"nctId":"NCT01755559","phase":"PHASE4","title":"Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger","status":"COMPLETED","sponsor":"Epicentre","startDate":"2013-06","conditions":"Malaria","enrollment":663},{"nctId":"NCT00808951","phase":"PHASE4","title":"In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2008-12","conditions":"Malaria","enrollment":440},{"nctId":"NCT01697787","phase":"PHASE4","title":"Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2012-10","conditions":"Malaria","enrollment":150},{"nctId":"NCT01017770","phase":"PHASE4","title":"Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2008-09","conditions":"Uncomplicated P. Falciparum Malaria in Children","enrollment":340},{"nctId":"NCT01350856","phase":"PHASE4","title":"Tracking Resistance to Artemisinin (TRAC)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2011-05","conditions":"Falciparum Malaria","enrollment":1700},{"nctId":"NCT01374581","phase":"PHASE3","title":"Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria","status":"COMPLETED","sponsor":"Universiteit Antwerpen","startDate":"2012-05","conditions":"Malaria","enrollment":2117},{"nctId":"NCT02168569","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2011-06","conditions":"Malaria","enrollment":700},{"nctId":"NCT00393679","phase":"PHASE3","title":"Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2007-07","conditions":"Fever, Malaria","enrollment":4112},{"nctId":"NCT00697892","phase":"PHASE1","title":"Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations","status":"COMPLETED","sponsor":"Fran Aweeka","startDate":"2005-07","conditions":"HIV Infections, Malaria","enrollment":38},{"nctId":"NCT01326754","phase":"NA","title":"Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2011-08","conditions":"Malaria, Falciparum","enrollment":498},{"nctId":"NCT00164710","phase":"PHASE4","title":"Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2005-04","conditions":"Malaria, Falciparum","enrollment":365},{"nctId":"NCT01152931","phase":"PHASE3","title":"Antioxidant Micronutrients in Malaria","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2010-08","conditions":"Malaria","enrollment":10},{"nctId":"NCT01567423","phase":"NA","title":"Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Epicentre","startDate":"2008-04","conditions":"Malaria, Falciparum","enrollment":301},{"nctId":"NCT00720811","phase":"NA","title":"Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2009-10","conditions":"Malaria, Pneumonia","enrollment":6456},{"nctId":"NCT00540410","phase":"PHASE4","title":"Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-09","conditions":"Malaria","enrollment":366},{"nctId":"NCT00902811","phase":"PHASE4","title":"Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria","status":"UNKNOWN","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2008-12","conditions":"Uncomplicated Falciparum Malaria","enrollment":600},{"nctId":"NCT00316329","phase":"PHASE3","title":"ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-03","conditions":"Malaria","enrollment":1032},{"nctId":"NCT00460369","phase":"NA","title":"Treatment of Uncomplicated Malaria in Benin","status":"COMPLETED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2007-04","conditions":"Uncomplicated Malaria","enrollment":240},{"nctId":"NCT00374205","phase":"PHASE4","title":"Randomized Trial on Effectiveness of ACTs in Ghana","status":"TERMINATED","sponsor":"Bernhard Nocht Institute for Tropical Medicine","startDate":"2006-09","conditions":"Malaria, Falciparum","enrollment":245},{"nctId":"NCT00406146","phase":"PHASE3","title":"Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children","status":"UNKNOWN","sponsor":"University of Ghana Medical School","startDate":"2004-10","conditions":"Uncomplicated Malaria","enrollment":""},{"nctId":"NCT00127998","phase":"NA","title":"Antimalarial Drug Resistance in Mali","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2005-07","conditions":"Malaria","enrollment":1011},{"nctId":"NCT00157885","phase":"NA","title":"A Randomised Trial of Artekin and Artesunate & Amodiaquine for Uncomplicated Malaria in Timika, Papua, Indonesia.","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2005-07","conditions":"Malaria, Falciparum, Malaria, Vivax","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":155,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"amodiaquine+artesunate/artemether-lumefantrine","genericName":"amodiaquine+artesunate/artemether-lumefantrine","companyName":"University of Ghana Medical School","companyId":"university-of-ghana-medical-school","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amodiaquine is a chloroquine derivative that acts as an antimalarial agent by inhibiting the parasite's heme detoxification pathway, while artesunate and artemether-lumefantrine are artemisinin-based combination therapies that rapidly kill the parasite. Used for Treatment of uncomplicated malaria, Treatment of severe malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}